22:01 , Jun 17, 2019 |  BC Extra  |  Financial News

Viela's $75M series B to support BLA, autoimmune pipeline

After attracting multiple crossover investors to its latest venture round, Viela’s $75 million series B could be the last private round for the MedImmune spinout. HBM Healthcare Investments led the financing with participation from fellow...
21:13 , Jan 5, 2018 |  BC Week In Review  |  Financial News

NexImmune raises $23M series A

NexImmune Inc. (Gaithersburg, Md.) raised $23 million on Jan. 2 in a series A round co-led by new investor ArrowMark Partners and existing investor Barer & Son Capital. Existing investor Piedmont Capital also participated. The...
21:01 , Jan 2, 2018 |  BC Extra  |  Financial News

NexImmune raises $23M series A

NexImmune Inc. (Gaithersburg, Md.) raised $23 million in a series A round co-led by new investor ArrowMark Partners and existing investor Barer & Son Capital. Existing investor Piedmont Capital also participated. The immuno-oncology company expects...